REG - Agronomics Limited - Agronomics invests US$ 2 million in SuperMeat

AgronomicsAnnouncement

21/11/2025 08:00

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251121:nRSU5306Ia&default-theme=true

RNS Number : 5306I  Agronomics Limited  21 November 2025

21 November 2025

 

Agronomics Limited (https://agronomics.im/)

("Agronomics" or the "Company")

 

Agronomics invests US$ 2 million in SuperMeat

Issue of Equity and TVR

 

Agronomics Limited (LSE: ANIC), the leading listed company focused on clean
food, is pleased to announce that its portfolio company SuperMeat ("SuperMeat
The Essence of Meat Ltd") has raised US$ 3.5 million in funding through the
issue of a Simple Agreement for Future Equity (a "SAFE"), of which Agronomics
will invest US$ 2 million in the form of US$ 0.75 million in cash and US$ 1.25
million in new Agronomics shares ("New Shares"), with Milk and Honey Ventures
also investing. The terms of both the SAFE and New Shares are outlined below.
The new funding will help support SuperMeat as it commercialises the
production of its premium-quality cultivated chicken in Europe.

 

In March 2024, SuperMeat released a life-cycle analysis, conducted by CE
Delft, which estimated that its cultivated chicken could produce roughly 50%
fewer carbon emissions than conventionally farmed chicken. In November 2024,
SuperMeat also announced a major cost-efficiency breakthrough: the ability to
produce 100% cultivated chicken (85% muscle, 15% fat) at approximately
US$11.79 per pound at scale, aligning cost with premium pasture-raised chicken
in the US.

 

Jim Mellon, Executive Chair of Agronomics said: "We are proud to further
increase our investment in SuperMeat and its team. As global demand for
protein continues to rise, it is essential to meet this demand sustainably,
reducing the environmental and health impacts associated with industrial
agriculture. Companies such as SuperMeat and its partners are delivering the
science, technology, and commercial readiness necessary to drive meaningful
change. Its progress toward industrial-scale cultivated meat represents not
only a compelling financial opportunity but also a strategic shift toward a
cleaner, more resilient, and technologically advanced future for food."

 

Ido Savir, co-founder and CEO of SuperMeat adds: "We're honored by Agronomics'
continued support and confidence in our work. Over the past year we have made
substantial advancements across our production platform, for the first time,
making cultivated chicken production commercially viable, and are now focused
on translating these achievements into commercial launch. This investment
supports our progress toward bringing cultivated chicken to market with
partners who understand how significant this category can become as demand and
expectations evolve."

 

 

Agronomics' Investment

SuperMeat is raising up to US$ 4.5 million through the issue of a SAFE which
allows subscribers to convert their investment into equity at the next
qualifying fund raise or other liquidity event at a discount rate of 70%,
capped at a post money valuation of US$ 35 million.

 

Agronomics will invest US$ 2 million into the SAFE, split into US$ 750,000 in
cash and issue the equivalent of US$ 1.25 million in New Shares at a share
price equivalent to the Company's NAV as at 30 September 2025. At the current
exchange rate, this represents £950,570, which divided by Agronomics' NAV of
14.65 pence announced on 13 November 2025, equates to 6,488,535 New Shares.

 

Agronomics first invested in SuperMeat in December 2020 and, prior to this
round, invested a total of £9.4 million, which, subject to audit, is
currently carried at approximately £14.2 million. This position represents
around 9.6% of Agronomics' most recently reported Net Asset Value of £147.8
million as of 30 September 2025.

 

TVR

Application has been made for the total of 6,488,535 New Shares to satisfy the
issue, which will rank pari passu with all existing Ordinary Shares, to be
admitted to trading on AIM. Admission is expected on or around 27 November
2025.

 

Following the issue of the New Shares, the Company's issued share capital will
consists of 1,015,905,830 Ordinary Shares of no-par value, with voting rights
("Ordinary Shares"). The Company does not hold any Ordinary Shares in
Treasury. Shareholders should therefore use 1,015,905,830 (being the Company's
issued share capital) as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or a change
to their interest in, the Company under the Financial Conduct Authority's
Disclosure and Transparency Rules.

 

ENDS

 

About SuperMeat

SuperMeat stands at the forefront of the cultivated meat sector, championing
the move towards sustainable, nutritious, and animal-friendly meat production.
The company has established a pivotal continuous process, setting a new
standard in the production of cultivated meat. SuperMeat has formed strategic
partnerships with leading food companies, underscoring its commitment to
working together to create a better food system

About Agronomics

Agronomics is a leading London-listed company focused on investment
opportunities within the field of cellular agriculture. The Company has
established a portfolio of over 25 companies developing technologies that
produce food and materials historically derived from animals, offering
solutions for improved sustainability, human health, and food security.

 

A full list of Agronomics' portfolio companies is available at
www.agronomics.im (http://www.agronomics.im) .

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET
ABUSE REGULATION (EU No. 596/2014) AS IT FORMS PART OF UK DOMESTIC LAW BY
VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018. UPON THE PUBLICATION OF
THIS ANNOUNCEMENT VIA A REGULATORY INFORMATION SERVICE, THIS INSIDE
INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN AND SUCH PERSONS
SHALL THEREFORE CEASE TO BE IN POSSESSION OF INSIDE INFORMATION.

For further information, please contact:

 Agronomics Limited   Beaumont              Canaccord Genuity     Cavendish Capital     33Seconds

                      Cornish Limited       Limited               Markets               Limited

                                                                  Limited
 The Company          Nomad                 Joint Broker          Joint Broker          Public Relations
 Jim Mellon           Roland Cornish        Andrew Potts          Giles Balleny         Jack Ferris

 Denham Eke           James Biddle          Harry Pardoe          Michael Johnson       Amber Carr

 +44 (0) 1624 639396  +44 (0) 207 628 3396  +44 (0) 207 523 8000  +44 (0) 207 397 8900  agronomics@33seconds.co

 info@agronomics.im

 

Nominated Adviser

 

Beaumont Cornish Limited ("Beaumont Cornish") is the Company's Nominated
Adviser and is authorised and regulated by the FCA. Beaumont Cornish's
responsibilities as the Company's Nominated Adviser, including a
responsibility to advise and guide the Company on its responsibilities under
the AIM Rules for Companies and AIM Rules for Nominated Advisers, are owed
solely to the London Stock Exchange. Beaumont Cornish is not acting for and
will not be responsible to any other persons for providing protections
afforded to customers of Beaumont Cornish nor for advising them in relation to
the proposed arrangements described in this announcement or any matter
referred to in it.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  MSCFESSWFEISEIF



            Copyright 2019 Regulatory News Service, all rights reserved